Session IV: ESMO Session: Focus on Young Oncologists (YO) in Collaboration With ESMO Young Oncologist Committee (YOC)

Chair(s)

• 

  Andrés Cervantes, MD, PhD

  Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia
  Valencia, Spain
• 

  Claudia Cardone, MD, PhD

  Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale”
  Napoli, Italy
• 

  Rille Pihlak, MD, PhD

  St Bart's Hospital
  London, United Kingdom
• 

  Elene Mariamidze, MD

  Todua Clinic
  Tbilisi, Georgia

Presentations:

• 08:00 – 08:15

  Scientific Part: Novel Predictive Biomarkers for Treatment (including immunotherapy) in Upper GI Cancers
  

  Speaker: Elizabeth C. Smyth, MD – Cambridge University Hospitals, NHS Foundation Trust
• 08:15 – 08:30

  Scientific Part: Novel Predictive Biomarkers for Treatment in Lower GI Cancers
  

  Speaker: Noelia Tarazona
• 08:30 – 08:45

  Scientific Part: Q&A and Panel Discussion
  

  Moderator: Claudia Cardone, MD, PhD – Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale”

  Moderator: Andrés Cervantes, MD, PhD – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia

  Moderator: Rille Pihlak, MD, PhD – St Bart's Hospital

  Moderator: Elene Mariamidze, MD – Todua Clinic
• 08:45 – 09:00

  Mentorship Part: What a Successful Career in GI Oncology Looks Like
  

  Speaker: Chiara Cremolini, MD PhD – Università di Pisa
• 09:00 – 09:15

  Mentorship Part: Writing Your First Grant Application
  

  Speaker: Joaquin Mateo, MD PhD – Vall d'Hebron Institute of Oncology
• 09:15 – 09:25

  Mentorship Part: Q&A and Panel Discussion
  

  Moderator: Claudia Cardone, MD, PhD – Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale”

  Moderator: Andrés Cervantes, MD, PhD – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia

  Moderator: Rille Pihlak, MD, PhD – St Bart's Hospital

  Moderator: Elene Mariamidze, MD – Todua Clinic

  Panelist: Chiara Cremolini, MD PhD – Università di Pisa

  Panelist: Joaquin Mateo, MD PhD – Vall d'Hebron Institute of Oncology